Intuity Medical (Sunnyvale, CA) a clinical-stage diagnostic device company focused on all-in-one blood sample collection and glucose analysis, closed a Series D financing. Participants include Venrock, Emergent Medical Partners, Investor Growth Capital, Thomas McNerney and Partners, U.S. Venture Partners and Versant Ventures.

On-Q-lty (Waltham, MA) a development stage molecular diagnostics company incorporating microfluidics and biomarker panels to predict response to cancer therapy based on DNA repair pathways in tumors, closed a $5M Series A financing, bringing the total round to $26M. Participants include Atlas Venture, Mohr Davidow Ventures, Bessemer Venture Partners, Physic Ventures and Northgate Capital.
Note: [...]

Ortho Kinematics (Austin, TX) a development-stage spine diagnostics company focused on inter-vertebral motion analysis, closed a $2M Series A financing. Participants include PTV Sciences, Texas Emerging Technology Fund and Gatebridge Investments.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Kreatech Diagnostics (Netherlands) a commercial-stage molecular diagnostics company focused on DNA FISH probes and nucleic acid labeling technologies, closed a $2.7M Series B financing. Participants include Alafi Capital and Life Science Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Tethys Bioscience (Emeryville, CA) a commercial-stage diagnostics company focused on type II diabetes risk assessment through the measurement of multiple biomarkers, closed a $25M Series D financing. Participants include Capital AG, Wasatch Advisors, Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

MTM Laboratories (Germany) a commercial-stage molecular diagnostics company focused on cervical cancer, closed on an $10M bringing the Series C financing to $56M. Participants includeGilde Healthcare Partners , LBBW Venture Capital, HBM BioVentures, and HBM BioCapital.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Accumetircs (San Diego,CA) a commercial-stage diagnostic company focused on VerifyNow® System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies, closed a $16.5M Series E financing. Participants inlcude Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Kaiser Permanente Ventures and RiverVest Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming [...]

PharmaDiagnostics (Brussels) a development-stage diagnostic services company focused on drug discovery screening technology based on localised surface plasmon resonance and noble metal nanoparticles in solution, closed a $3.7M Series B financing. Participants include Capital-E.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Integrated Diagnostics (Seattle, WA) a development-stage diagnostics company focused on rapid biomarker validation and parallel organ-centric assays, closed a $30M Series A financing. Participants include Interwest Partners, The Wellcome Trust and Dievini Hopp Biotech Holding.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Nodality (San Francisco, CA) a development-stage molecular diagnostics company focused on hematological malignancies and autoimmune disorders, closed a $3.5M Series C financing. Participants have included Kleiner Perkins Caufield & Byers, Maverick Capital, Pfizer and TPG Ventures.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.